Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Sudden severe thrombocytopenia after transfusion?
Think Post-Transfusion Purpura (PTP).
One of the most under-recognized yet critical delayed transfusion reactions in clinical practice is Post-Transfusion Purpura (PTP) — and missing it can delay life-saving treatment.
What is PTP?
A rare, immune-mediated complication that typically appears 5–10 days after transfusion, most often in previously pregnant or transfused patients, especially women.
What causes it?
The development of platelet alloantibodies, commonly anti-HPA-1a, which trigger destruction of both transfused platelets and the patient’s own platelets.
What happens clinically?
- Sudden severe thrombocytopenia (less than 10 × 10⁹/L)
- Petechiae, purpura, mucosal bleeding
- Risk of serious hemorrhage if untreated
Key diagnostic clues.
- Recent transfusion history
- Critically low platelet count
- Detection of anti-platelet antibodies
- Exclusion of other causes like TTP and ITP
Treatment is urgent — and effective when started early.
- IVIg (first-line therapy)
- Steroids as adjunct
- Plasma exchange in refractory cases
Avoid platelet transfusion unless life-threatening bleeding.
The most important takeaway?
PTP is treatable — but only if recognized early.
When unexplained severe thrombocytopenia appears days after transfusion, pause and consider PTP.
Early recognition saves lives.
Signature of Blood Doki.
Educate. Empower. Elevate.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications